These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27908754)

  • 1. Cyclic citrullinated MBP
    Apostolopoulos V; Deraos G; Matsoukas MT; Day S; Stojanovska L; Tselios T; Androutsou ME; Matsoukas J
    Bioorg Med Chem; 2017 Jan; 25(2):528-538. PubMed ID: 27908754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of myelin altered peptide ligand cyclo(87-99)(Ala91,Ala96)MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosis.
    Deraos G; Rodi M; Kalbacher H; Chatzantoni K; Karagiannis F; Synodinos L; Plotas P; Papalois A; Dimisianos N; Papathanasopoulos P; Gatos D; Tselios T; Apostolopoulos V; Mouzaki A; Matsoukas J
    Eur J Med Chem; 2015 Aug; 101():13-23. PubMed ID: 26112377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cyclic Altered Peptide Analogue Based on Myelin Basic Protein 87-99 Provides Lasting Prophylactic and Therapeutic Protection Against Acute Experimental Autoimmune Encephalomyelitis.
    Emmanouil M; Tseveleki V; Triantafyllakou I; Nteli A; Tselios T; Probert L
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29385090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered peptide ligands of myelin basic protein ( MBP87-99 ) conjugated to reduced mannan modulate immune responses in mice.
    Katsara M; Yuriev E; Ramsland PA; Tselios T; Deraos G; Lourbopoulos A; Grigoriadis N; Matsoukas J; Apostolopoulos V
    Immunology; 2009 Dec; 128(4):521-33. PubMed ID: 19930042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses of linear and cyclic PLP139-151 mutant peptides in SJL/J mice: peptides in their free state versus mannan conjugation.
    Katsara M; Deraos S; Tselios TV; Pietersz G; Matsoukas J; Apostolopoulos V
    Immunotherapy; 2014; 6(6):709-24. PubMed ID: 25186603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of experimental allergic encephalomyelitis (EAE) induced by guinea pig myelin basic protein epitope 72-85 with a human MBP(87-99) analogue and effects of cyclic peptides.
    Tselios T; Daliani I; Probert L; Deraos S; Matsoukas E; Roy S; Pires J; Moore G; Matsoukas J
    Bioorg Med Chem; 2000 Aug; 8(8):1903-9. PubMed ID: 11003134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A putative bioactive conformation for the altered peptide ligand of myelin basic protein and inhibitor of experimental autoimmune encephalomyelitis [Arg91, Ala96] MBP87-99.
    Mantzourani ED; Tselios TV; Grdadolnik SG; Brancale A; Platts JA; Matsoukas JM; Mavromoustakos TM
    J Mol Graph Model; 2006 Sep; 25(1):17-29. PubMed ID: 16310386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms.
    Gaur A; Boehme SA; Chalmers D; Crowe PD; Pahuja A; Ling N; Brocke S; Steinman L; Conlon PJ
    J Neuroimmunol; 1997 Apr; 74(1-2):149-58. PubMed ID: 9119968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production.
    Karin N; Mitchell DJ; Brocke S; Ling N; Steinman L
    J Exp Med; 1994 Dec; 180(6):2227-37. PubMed ID: 7525850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active immunization with myelin-derived altered peptide ligand reduces mechanical pain hypersensitivity following peripheral nerve injury.
    Perera CJ; Duffy SS; Lees JG; Kim CF; Cameron B; Apostolopoulos V; Moalem-Taylor G
    J Neuroinflammation; 2015 Feb; 12():28. PubMed ID: 25885812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular dynamics at the receptor level of immunodominant myelin basic protein epitope 87-99 implicated in multiple sclerosis and its antagonists altered peptide ligands: triggering of immune response.
    Mantzourani ED; Platts JA; Brancale A; Mavromoustakos TM; Tselios TV
    J Mol Graph Model; 2007 Sep; 26(2):471-81. PubMed ID: 17392002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The major histocompatibility complex influences myelin basic protein 63-88-induced T cell cytokine profile and experimental autoimmune encephalomyelitis.
    Mustafa M; Vingsbo C; Olsson T; Ljungdahl A; Höjeberg B; Holmdahl R
    Eur J Immunol; 1993 Dec; 23(12):3089-95. PubMed ID: 7504988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking.
    Aharoni R; Teitelbaum D; Arnon R; Sela M
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):634-9. PubMed ID: 9892685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial epitopes act as altered peptide ligands to prevent experimental autoimmune encephalomyelitis.
    Ruiz PJ; Garren H; Hirschberg DL; Langer-Gould AM; Levite M; Karpuj MV; Southwood S; Sette A; Conlon P; Steinman L
    J Exp Med; 1999 Apr; 189(8):1275-84. PubMed ID: 10209044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats.
    Stepaniak JA; Gould KE; Sun D; Swanborg RH
    J Immunol; 1995 Sep; 155(5):2762-9. PubMed ID: 7544385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of active immunisation with myelin basic protein and myelin-derived altered peptide ligand on pain hypersensitivity and neuroinflammation.
    Perera CJ; Lees JG; Duffy SS; Makker PG; Fivelman B; Apostolopoulos V; Moalem-Taylor G
    J Neuroimmunol; 2015 Sep; 286():59-70. PubMed ID: 26298325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide.
    Leadbetter EA; Bourque CR; Devaux B; Olson CD; Sunshine GH; Hirani S; Wallner BP; Smilek DE; Happ MP
    J Immunol; 1998 Jul; 161(1):504-12. PubMed ID: 9647262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
    Takács K; Chandler P; Altmann DM
    Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of proposed putative active conformations of myelin basic protein epitope 87-99 linear altered peptide ligands by spectroscopic and modelling studies: the role of positions 91 and 96 in T-cell receptor activation.
    Mantzourani ED; Tselios TV; Grdadolnik SG; Platts JA; Brancale A; Deraos GN; Matsoukas JM; Mavromoustakos TM
    J Med Chem; 2006 Nov; 49(23):6683-91. PubMed ID: 17154499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of novel cyclic altered peptide ligands of myelin basic protein MBP83-99 that modulate immune responses in SJL/J mice.
    Katsara M; Deraos G; Tselios T; Matsoukas J; Apostolopoulos V
    J Med Chem; 2008 Jul; 51(13):3971-8. PubMed ID: 18563891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.